SPA
ELV icon

Sherbrooke Park Advisers’s Elevance Health ELV Stock Holding History

Sherbrooke Park Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,245
Closed -$542K – 534
2023
Q3 		$542K Buy
+1,245
New +$565K 0.17% 221
2023
Q1 		– Sell
-1,000
Closed -$513K – 222
2022
Q4 		$513K Buy
+1,000
New +$508K 0.38% 115

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sherbrooke Park Advisers's ELV Position: Q4 2023 in Review

Sherbrooke Park Advisers sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 1,245 shares — an estimated $542K sold.

Sherbrooke Park Advisers first reported a position in ELV in Q4 2022 and held it in 2 quarters. The position peaked at $542K in Q3 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Sherbrooke Park Advisers reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,245 Elevance Health shares in Q4 2023, an estimated $542K.
  • Sherbrooke Park Advisers first reported a position in Elevance Health in Q4 2022 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Elevance Health position peaked at $542K in Q3 2023.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.